Citation Impact
Citing Papers
Antibody-Mediated Rejection in Cardiac Transplantation: Emerging Knowledge in Diagnosis and Management
2015
Treatment of Vascular Rejection With Rituximab in Cardiac Transplantation
2005
Increasing the Opportunity of Live Kidney Donation by Matching for Two- and Three-Way Exchanges
2006 StandoutNobel
A Single Low-Fixed Dose of Rituximab to Salvage Renal Transplants From Refractory Antibody-Mediated Rejection
2009
Risk and prevention of graft failure in patients with preexisting donor-specific HLA antibodies undergoing unmanipulated haploidentical SCT
2011
Intravenous Immunoglobulin Induction Treatment in Flow Cytometry Cross-Match—Positive Kidney Transplant Recipients
2005
Comparison of Combination Plasmapheresis/IVIg/ Anti-CD20 Versus High-Dose IVIg in the Treatment of Antibody-Mediated Rejection
2009
The Acceptable Mismatch Program as a Fast Tool for Highly Sensitized Patients Awaiting a Cadaveric Kidney Transplantation: Short Waiting Time and Excellent Graft Outcome
2004
Preexisting Donor-Specific HLA Antibodies Predict Outcome in Kidney Transplantation
2010 Standout
PLASMAPHERESIS AND INTRAVENOUS IMMUNE GLOBULIN PROVIDES EFFECTIVE RESCUE THERAPY FOR REFRACTORY HUMORAL REJECTION AND ALLOWS KIDNEYS TO BE SUCCESSFULLY TRANSPLANTED INTO CROSS-MATCH-POSITIVE RECIPIENTS
2000
Posttransplant Prophylactic Intravenous Immunoglobulin in Kidney Transplant Patients at High Immunological Risk: A Pilot Study
2007
Complement-Binding Anti-HLA Antibodies and Kidney-Allograft Survival
2013 Standout
Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors
2019 Standout
C4d and C3d Staining in Biopsies of ABO- and HLA-Incompatible Renal Allografts: Correlation with Histologic Findings
2006
Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients1
2003
Extending options for highly sensitized patients to receive a suitable kidney graft
2005
Frequency and Clinical Implications of Development of Donor-Specific and Non–Donor-Specific HLA Antibodies after Kidney Transplantation
2005
Summary of FDA Antibody-Mediated Rejection Workshop
2011
OKT3 Therapy in Addition to Tacrolimus Is Associated with Improved Long-Term Function in Patients with Steroid Refractory Renal Allograft Rejection
2006
Graft-versus-host disease
2009 Standout
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Salinomycin: A Novel Anti-Cancer Agent with Known Anti-Coccidial Activities
2013
Evaluation of Intravenous Immunoglobulin as an Agent to Lower Allosensitization and Improve Transplantation in Highly Sensitized Adult Patients with End-Stage Renal Disease
2004
Strategies to Improve Long-Term Outcomes after Renal Transplantation
2002 Standout
Antibody-Mediated Rejection in Renal Allografts
2006
Diabetes, Smoking, Alcohol Use, and Family History of Cancer as Risk Factors for Pancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis
2015
Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
2017 StandoutNature
Subclinical Acute Antibody-Mediated Rejection in Positive Crossmatch Renal Allografts
2007
A Survey of Current Practice for Antibody-Mediated Rejection in Heart Transplantation
2013
Prevention and treatment of alloantibody-mediated kidney transplant rejection
2011
Current usage of intravenous immune globulin and the rationale behind it: the Massachusetts General Hospital data and a review of the literature
2006
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
HLA-Mismatched Renal Transplantation without Maintenance Immunosuppression
2008 Standout
Humoral Theory of Transplantation
2003
ACUTE HUMORAL REJECTION IN RENAL ALLOGRAFT RECIPIENTS: I. INCIDENCE, SEROLOGY AND CLINICAL CHARACTERISTICS1
2001
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Therapeutic plasma exchange for desensitization prior to transplantation in ABO‐incompatible renal allografts
2009
Treatment of antibody‐mediated rejection in renal transplant patients: a clinical practice survey
2014
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Salinomycin as a Drug for Targeting Human Cancer Stem Cells
2012
Kidney paired donation
2011 StandoutNobel
Evolution and Clinical Pathologic Correlations of De Novo Donor-Specific HLA Antibody Post Kidney Transplant
2012 Standout
Translational Therapeutic Opportunities in Ductal Adenocarcinoma of the Pancreas
2012
Multi-targeted therapy of cancer by niclosamide: A new application for an old drug
2014 Standout
Antibody‐Mediated Rejection in Kidney Transplantation: A Review of Pathophysiology, Diagnosis, and Treatment Options
2014
Works of Ge Chen being referenced
Risk factors for the occurrence of insulinoma: a case-control study
2013
POSTTRANSPLANT THERAPY USING HIGH-DOSE HUMAN IMMUNOGLOBULIN (INTRAVENOUS GAMMAGLOBULIN) TO CONTROL ACUTE HUMORAL REJECTION IN RENAL AND CARDIAC ALLOGRAFT RECIPIENTS AND POTENTIAL MECHANISM OF ACTION1
1998
Combination of salinomycin and gemcitabine eliminates pancreatic cancer cells
2011